Tom Large

Tom Large has a diverse work experience spanning over several decades. Tom began their career in 1985 as a Postdoctoral Fellow at the Howard Hughes Medical Institute. From there, they moved on to become an Assistant Professor at Case Western Reserve University School of Medicine in 1989. In 1997, they joined Eli Lilly and Company, where they held various roles, including Head and Group Manager. In 2007, they transitioned to Sunovion Pharmaceuticals Inc. as Senior Vice President of Preclinical Research and Translational Medicine. Most recently, in 2016, Tom co-founded Blue Oak Pharmaceuticals and assumed the position of CEO.

Tom Large attended Northwestern University from 1976 to 1985, during which they pursued a BA/MS/PhD degree in Neuroscience and Physiology.